(RCUS) Arcus Biosciences - Performance -37.4% in 12m
RCUS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-74.07%
#111 in Peer-Group
Rel. Strength
14.27%
#6589 in Stock-Universe
Total Return 12m
-37.42%
#106 in Peer-Group
Total Return 5y
-60.02%
#71 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 18.44 USD |
| 52 Week Low | 6.87 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 88.14 |
| Buy/Sell Signal +-5 | 1.83 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RCUS (-37.4%) vs XBI (-11.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.14% | 63.4% | 78.7% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
3.16% | -9.04% | 157% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.5% | -7.13% | 36% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
8.1% | -8.36% | 1.32% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-0.99% | 26.5% | -5.28% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
8.81% | 38.5% | -10.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.65% | 49.3% | -10.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.76% | 27.6% | 14.6% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: RCUS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RCUS
| Total Return (including Dividends) | RCUS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 6.16% | 5.89% | 3.98% |
| 3 Months | 25.65% | 15.34% | 16.24% |
| 12 Months | -37.42% | -11.61% | 12.66% |
| 5 Years | -60.02% | -23.80% | 109.18% |
| Trend Score (consistency of price movement) | RCUS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -0.3% | 65.7% | 91.4% |
| 3 Months | 45.9% | 79.4% | 97.5% |
| 12 Months | -81.6% | -87.3% | 46.7% |
| 5 Years | -81.9% | -51.8% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th54.50 | 0.26% | 2.10% |
| 3 Month | %th60.50 | 8.94% | 8.10% |
| 12 Month | %th47.00 | -29.20% | -44.45% |
| 5 Years | %th64.50 | -47.54% | -80.89% |
FAQs
Does Arcus Biosciences (RCUS) outperform the market?
No,
over the last 12 months RCUS made -37.42%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.61%.
Over the last 3 months RCUS made 25.65%, while XBI made 15.34%.
Performance Comparison RCUS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RCUS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 16.7% | 2.2% | -38.1% | -50% |
| US NASDAQ 100 | QQQ | 16.6% | 1.9% | -40.6% | -50% |
| German DAX 40 | DAX | 17% | 4.2% | -48.8% | -67% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 15.2% | 1% | -40.1% | -57% |
| Hongkong Hang Seng | HSI | 15.9% | 3.6% | -59.5% | -72% |
| India NIFTY 50 | INDA | 18.2% | 5.5% | -38% | -34% |
| Brasil Bovespa | EWZ | 21.9% | 9.7% | -51.3% | -37% |
RCUS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 17.4% | 3.3% | -42.8% | -62% |
| Consumer Discretionary | XLY | 15.6% | 2.1% | -30.9% | -55% |
| Consumer Staples | XLP | 18.9% | 5.9% | -37.2% | -45% |
| Energy | XLE | 15.1% | 5% | -28.4% | -37% |
| Financial | XLF | 17.7% | 1.8% | -39.9% | -61% |
| Health Care | XLV | 16.9% | 6.2% | -27.5% | -30% |
| Industrial | XLI | 16% | 0.7% | -43.2% | -60% |
| Materials | XLB | 16.8% | 2.4% | -36.8% | -40% |
| Real Estate | XLRE | 16.5% | 5.5% | -36.4% | -45% |
| Technology | XLK | 17.1% | 0.8% | -42.8% | -47% |
| Utilities | XLU | 16.5% | 3.3% | -41.1% | -60% |
| Aerospace & Defense | XAR | 14.4% | -3.7% | -58.7% | -87% |
| Biotech | XBI | 11.8% | 0.3% | -32% | -26% |
| Homebuilder | XHB | 14.6% | -3.1% | -27.9% | -34% |
| Retail | XRT | 16.3% | 1% | -34.8% | -45% |
RCUS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 18.5% | 9.94% | -22.8% | -32% |
| Natural Gas | UNG | 16.2% | 16.1% | -13% | -43% |
| Gold | GLD | 17.2% | 7.4% | -54.9% | -75% |
| Silver | SLV | 13.8% | 1.3% | -57.5% | -61% |
| Copper | CPER | 7.4% | -7.4% | -56% | -60% |
RCUS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 18% | 5.6% | -32.7% | -34% |
| iShares High Yield Corp. Bond | HYG | 17.4% | 5% | -35% | -46% |